China's White Paper on Industrial Biotechnology and China's Bio-Industry Investment Analysis Report 2017.

The Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences and the Chengdu Documentation And Information Center of the Chinese Academy of Sciences jointly released the White Paper on Industrial Biotechnology in China and the China Bioindustrial Investment Analysis Report 2017.
data show that in 2014-2016, China performed well in basic research and technological innovation in industrial biotechnology, with a total of 11,266 e-mails issued in 2016, surpassing the United States as the number one country in terms of annual issuance, and the number of patents filed reached 120,686, ranking first in the world.
2014-2016, China has published 29939 papers on synthetic biotechnology, bio-based chemicals, bio-based materials, biosensors, etc., with the Chinese Academy of Sciences, Zhejiang University and Jiangnan University among the leading research and development units.
the same period, China became the leading country for the protection of industrial biotechnology invention patents, with a total of 57,559 patent applications for inventions and 21,947 patents granted for inventions in three years, with a total of 1107 applications for pct patents, the number of applications increased year by year, with a compound annual growth rate of 11%.
the White Paper on Industrial Biotechnology in China and the China Bioindustrial Investment Analysis Report 2017, it is pointed out that of the 57,559 patent applications for Chinese inventions of industrial biotechnology, 86% were patented inventions by Chinese applicants, compared with only 14% of other countries.
of the 21,947 patents granted by Chinese inventions for industrial biotechnology, 78% are patented inventions by Chinese applicants, and 22% of other countries are.
it can be seen that foreign applicants in China to apply for industrial biotechnology invention patents more competitive, licensing ratio is higher.
Despite the world's leading number of patents for inventions in industrial biotechnology, the number of Chinese applicants applying for patents abroad is very small.
the "China Industrial Biotechnology White Paper and China's Bioindustrial Investment Analysis Report 2017" that, after continuous development, China's industrial biotechnology development has a certain industrial pattern, independent innovation ability has been significantly enhanced, production technology level has been greatly improved, gradually formed a market-oriented, enterprise-oriented, industry and research combined, upstream and downstream linkage of industrial technology innovation system.
.